<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222216/" ref="ordinalpos=4180&amp;ncbi_uid=4447289&amp;link_uid=PMC3222216" image-link="/pmc/articles/PMC3222216/figure/F7/" class="imagepopup">Fig. 7. From: Neural crest specification by noncanonical Wnt <span class="highlight" style="background-color:">signaling</span> and PAR-1. </a></div><br /><div class="p4l_captionBody"><b>PAR-1 functions in the Wnt5/11 pathway upstream of Pax3</b>. (<b>A</b>) PAR-1 RNA promotes Pax3 expression (stage 17). (<b>B</b>) PAR-1 is required for Pax3 expression (stage 14/15). (<b>C</b>,<b>D</b>) PAR-1 rescues the FoxD3 defect in embryos that were injected with dnWnt5/11 RNA. Dorso-anterior view, except A (dorsal view). Arrows indicate altered gene expression. (<b>E</b>) Model for Wnt11R signaling during NC specification. Dvl and the associated PAR-1 protein kinase are essential regulators of NC-specific transcription in response to Wnt11R/Ror2 signaling. Dashed lines represent indirect effects via unknown intermediates.</div></div>